Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	GBT440 600 mg Dose	9
Overall Study	STARTED	GBT440 900 mg Dose	6
Overall Study	STARTED	GBT440 1500 mg Dose	14
Overall Study	STARTED	Placebo	10
Overall Study	Completed Study Treatment	GBT440 600 mg Dose	7
Overall Study	Completed Study Treatment	GBT440 900 mg Dose	5
Overall Study	Completed Study Treatment	GBT440 1500 mg Dose	11
Overall Study	Completed Study Treatment	Placebo	10
Overall Study	COMPLETED	GBT440 600 mg Dose	7
Overall Study	COMPLETED	GBT440 900 mg Dose	6
Overall Study	COMPLETED	GBT440 1500 mg Dose	10
Overall Study	COMPLETED	Placebo	10
Overall Study	NOT COMPLETED	GBT440 600 mg Dose	2
Overall Study	NOT COMPLETED	GBT440 900 mg Dose	0
Overall Study	NOT COMPLETED	GBT440 1500 mg Dose	4
Overall Study	NOT COMPLETED	Placebo	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02846324/flow